Clinical Trial Update: A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares [Phase 4]

View source ↗

Summary

This clinical trial update notes a Phase 4 study evaluating spesolimab for Generalized pustular psoriasis, with status active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Pustular Psoriasis

Drugs mentioned

• SPESOLIMAB (BI655130)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Generalized Pustular Psoriasis | Phase 4 | Status: ACTIVE_NOT_RECRUITING